News

August 31, 2016August 31, 2016

Biologic DMARD Use May Lower Risk of Deadly Sepsis in RA Patients with Infections

News

Biological disease-modifying anti-rheumatic drugs appear to more effectively reduce the risk of sepsis after serious infection in patients with rheumatoid arthritis (RA) than conventional drugs of this nature, researchers reported, based on a study ... Read more

August 29, 2016August 29, 2016

Predictors Identified for Severe Cervical Spine Instabilities in RA Patients

News

Patients with rheumatoid arthritis (RA) are more likely to exhibit cervical spine instabilities if they have a history of corticosteroid treatment or joint surgery and the presence of mutilating changes, ... Read more

August 26, 2016August 26, 2016

Phase 3 Clinical Tests of Filgotinib in Range of RA Patients Getting Underway

News

Galapagos NV has recently initiated a global Phase 3 clinical program (FINCH) evaluating the safety and efficacy of filgotinib (100 mg and 200 mg once daily) in a range of ... Read more

August 24, 2016August 24, 2016

Rheumatoid Arthritis Patients on Kineret at High Risk of Strep Infections, Study Says

News

Rheumatoid arthritis patients using medications that are interleukin-1β (IL-1β) receptor antagonists, like Kineret (anakinra), may be at much higher risk of infections with Group A Streptococcal bacteria, a flesh-eating bacteria that is the cause ... Read more

August 22, 2016August 30, 2016

Rheumatoid Arthritis Patients Could Develop Second Autoimmune Condition

News

People with rheumatoid arthritis (RA) or other autoimmune diseases have a high likelihood of being impacted with a second autoimmune disorder. The question is why? Several explanations for the phenomenon were offered in ... Read more

August 19, 2016August 19, 2016

Johnson & Johnson to Appeal Court Ruling That Favors Biosimilar Competition

News

In a press release, Johnson & Johnson announced recently that a District of Massachusetts Federal Court has ruled on a summary judgment motion filed by Celltrion Healthcare and Hospira Healthcare Corporation in patent ... Read more

August 17, 2016August 17, 2016

Heart Attack Risk for RA Patients Linked to C-Reactive Protein

News

Rheumatoid arthritis (RA) patients who present high levels of inflammation markers have an increased risk for myocardial infarction (heart attack) according to the study “Impact of disease activity and treatment of comorbidities ... Read more

August 15, 2016August 15, 2016

Chances for Heart Disease with Rheumatoid Arthritis May Decrease Via HDL Control

News

Rheumatoid arthritis (RA) treatments can reduce the risk for cardiovascular diseases (CVD) when restoration of normal HDL anti-oxidant functions is achieved, according to researchers at the University of California Los Angeles ... Read more

August 12, 2016August 12, 2016

Lower-Cost Biosimilar Therapy Gets Unanimous FDA Panel Support

News

The US Food and Drug Administration’s (FDA) Arthritis Advisory Committee last month unanimously supported Amgen’s drug candidate ABP 501 as a biosimilar to Abbvie’s Humira (adalimumab). Amgen is seeking to ... Read more

August 10, 2016August 10, 2016

Cell Therapy Seen in Trial to Benefit RA Patients Who Don’t Respond to Biologics

News

Mesoblast has announced positive results of a Phase 2 clinical trial evaluating its lead mesenchymal precursor cell (MPC) therapy candidate, MPC-300-IV, in people with biologic refractory rheumatoid arthritis (RA). “The safety and ... Read more